BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12203875)

  • 1. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
    Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
    Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
    Wakely PE; Menezes G; Nuovo GJ
    Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
    Kaur K; Patel T; Patra S; Trivedi P
    Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
    Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
    Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
    Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
    Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
    Czader M; Ali SZ
    Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cytomorphologic and immunophenotypic approach to evaluation of effusions for lymphomatous involvement.
    Dunphy CH
    Diagn Cytopathol; 1996 Dec; 15(5):427-30. PubMed ID: 8989548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin and T-cell receptor gene rearrangement in Castleman's disease: molecular genetic analysis.
    Al-Maghrabi J; Kamel-Reid S; Bailey D
    Histopathology; 2006 Feb; 48(3):233-8. PubMed ID: 16430469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid.
    Das DK; Al-Juwaiser A; George SS; Francis IM; Sathar SS; Sheikh ZA; Shaheen A; Pathan SK; Haji BE; George J; Kapila K
    Cytopathology; 2007 Jun; 18(3):157-67. PubMed ID: 17488258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.
    Hallman JR; Geisinger KR
    Acta Cytol; 1994; 38(2):209-17. PubMed ID: 8147212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
    Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
    Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV- and HHV-8-negative primary effusion lymphoma-like lymphoma presenting with lymphomatous effusions complicated by cardiac tamponade-a case report].
    Taira T; Nagasaki A; Okudaira T; Miyagi T; Iha K; Takushi Y; Chinen I; Higa S; Nakayama T; Takasu N
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1195-8. PubMed ID: 19620817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.